UPC logo

UNIVERSE PHARMACEUTICAL-CL A

UPCNASDAQ
🏆 #4718 by market capUS Equity
$4.72▲ $0.82 (+17.27%)
Market closed · at close
🔔
Track UPC
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 17.3%
7d▲ 17.3%
14d▲ 17.3%
30d▼ 4.1%
ytd▲ 22.6%
1y▲ 7.0%
🏦Market Cap
$3M
Small Cap
📈Revenue Growth (YoY)
-22.3%
Declining
📊Gross Margin
35.3%
Healthy
💵FCF Margin
26.9%
Strong
⚖️P/S Ratio
1.4x
Cheap
Otter Score
44
Weak

Trading Snapshot

Day Range
$4.65 – $4.75
52-Week Range
$2.00 – $17.96
Volume
$2.88B
Avg Volume
$3.47B
Shares Outstanding
650,000
Next Earnings
Dec 3, 2026

Fundamentals Snapshot

Annual Revenue
$18M
Last Q Revenue
$9M
P/E Ratio
—
P/S Ratio
1.4x
EPS (TTM)
$-10.13
Dividend Yield
—
Dilution (1yr)
+9170.0%

Why Investors Own UPC

  • ✓High-growth profile — revenue up -7.5% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 37% gross margin and 15% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

UPC logo

UNIVERSE PHARMACEUTICAL-CL A

UPC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$18M▼ −22.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
35.3%▲ +33.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$3M▼ −63.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$5M▼ −45.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
563K▲ +9170.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$24M▲ +$3M YoY
StockOtter · stockotter.space

About UNIVERSE PHARMACEUTICAL-CL A

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
44/100

Analyst Price Target

ⓘ
Average Target
$6.05
▲ +28.2% Upside
High Target$6.95
Low Target$5.43
Based on 23 analysts

Latest News & Updates

🚀
MarketWatch·2h ago

UNIVERSE PHARMACEUTICAL-CL A tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift UPC price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

UNIVERSE PHARMACEUTICAL-CL A announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.